These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 215136)

  • 21. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
    Tremblay J; Hamet P
    Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium.
    Vigdahl RL; Marquis NR; Tavormina PA
    Biochem Biophys Res Commun; 1969 Oct; 37(3):409-15. PubMed ID: 4310667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM; Goldberg BJ; Smiley PA; Olson CV
    Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
    Egan CM; Fisher AP; Scrutton MC
    Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
    Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA; Hourani SM
    Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Mar; 72(3):443-7. PubMed ID: 7260485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
    Dutta-Roy AK; Ray TK; Sinha AK
    Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
    Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
    Droller MJ; Wolfe SM
    J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple effects of guanine nucleotides on human platelet adenylated cyclase.
    Tsai BS; Lefkowitz RJ
    Biochim Biophys Acta; 1979 Sep; 587(1):28-41. PubMed ID: 486544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
    Farndale RW; Winkler AB; Martin BR; Barnes MJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
    J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do human platelets have opiate receptors?
    Reches A; Eldor A; Vogel Z; Salomon Y
    Nature; 1980 Nov; 288(5789):382-3. PubMed ID: 6253832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.